Evaluating World Health Organization Essential Medicines List for Skin Disease.

Skin diseases comprise nearly 2% of all health burden and are the 4th leading cause of non-fatal disease globally.1 To address such needs, the World Health Organization List of Essential Medicines (WMLEM) aims to meet the basic needs of global communities by recommending effective, cost-efficient therapies. While an inherently difficult task, disparities are noted in the WMLEM.2 Herein, this letter utilizes Global Burden of Disease (GBD), Treatment of Skin Disease3 (5th edition) (TSD), and Evidence-Based Dermatology4 (3rd edition) (EBD) data, and expert opinion to explore the paucities of the current WMLEM.